title: Treatment of mesangial immunoglobulin A glomerulonephritis.
abstract: Mesangial immunoglobulin A glomerulonephritis does not progress unless microscopic hematuria presents at levels over 100,000/mL, proteinuria presents at levels over 0.5 g in 24 hours, or hypertension is inadequately controlled. Hypertension, microscopic hematuria, and proteinuria all can be controlled; the evidence for control of these three risk factors is reviewed. The evidence for prevention of progression in mesangial immunoglobulin A glomerulonephritis is also reviewed.
authors: Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
authors: P
authors: P
authors: Kincaid-Smith
mesh_terms: D018450:Disease Progression; D005260:Female; D005922:Glomerulonephritis, IGA / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D008297:Male; D012307:Risk Factors